CHARACTERIZATION OF ANTIGANGLIOSIDE ANTIBODIES PRESENT IN NORMAL HUMAN PLASMA

被引:60
作者
MIZUTAMARI, RK
WIEGANDT, H
NORES, GA
机构
[1] NATL UNIV CORDOBA,FAC CIENCIAS QUIM,DEPT QUIM BIOL,RA-5016 CORDOBA,ARGENTINA
[2] CONSEJO NACL INVEST CIENT & TECN,CIQUIBIC,RA-5016 CORDOBA,ARGENTINA
[3] UNIV MARBURG,INST PHYSIOL CHEM,D-35043 MARBURG,GERMANY
关键词
GANGLIOSIDES; ANTIGANGLIOSIDE ANTIBODIES; GM(1); NEUROPATHIES; AUTOANTIBODIES;
D O I
10.1016/0165-5728(94)90048-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Samples of plasma from normal human adults were screened for anti-ganglioside antibodies by HPTLC-immunostaining and enzyme-linked immunosorbent assay (ELISA). All the samples analyzed showed IgM-immunoreactivity to GM(1) ganglioside and its related glycolipid GA(1). Reactivity to GD(1b), GM(2) and LM(1) was also detected in 85, 80 and 20% of the analyzed samples, respectively. The main immunoreactivity is related to the asialo-ganglioside GA(1). Using inhibition by soluble antigen and affinity chromatography techniques it was possible to distinguish two populations of anti-GA(1) antibodies. One with high affinity reacting only with GA(1), and another with low affinity reacting also with GM(1) and GD(1b). The antibodies that recognize GM(2) are of low affinity and appear to be different from those that react with GA(1). We postulate that the anti-GM(1)/GD(1b) immunoreactivity present in normal human plasma could be a cross-reaction of antibodies originally directed to a GA(1)-like carbohydrate structure. Anti-GA(1) and anti-GM(1) titers were calculated as the reciprocal of the plasma dilution needed to obtain the half maximal antibody binding, a titer definition that we consider more suitable to compare data from different laboratories than those usually employed.
引用
收藏
页码:215 / 220
页数:6
相关论文
共 15 条
[1]  
CUMAR FA, 1968, J BIOL CHEM, V246, P5075
[2]   A NEW METHOD FOR PURIFICATION OF ANTI-GLYCOSPHINGOLIPID ANTIBODY - AVIAN ANTI-HEMATOSIDE (NEUGC) ANTIBODY [J].
HIRABAYASHI, Y ;
SUZUKI, T ;
SUZUKI, Y ;
TAKI, T ;
MATSUMOTO, M ;
HIGASHI, H ;
KATO, S .
JOURNAL OF BIOCHEMISTRY, 1983, 94 (01) :327-330
[3]   POLYNEUROPATHY WITH MONOCLONAL GAMMOPATHY - GLYCOLIPIDS ARE FREQUENTLY ANTIGENS FOR IGM PARAPROTEINS [J].
ILYAS, AA ;
QUARLES, RH ;
DALAKAS, MC ;
BRADY, RO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (19) :6697-6700
[4]   MONOCLONAL IGM WITH UNIQUE SPECIFICITY TO GANGLIOSIDES GM1 AND GD1B AND TO LACTO-N-TETRAOSE ASSOCIATED WITH HUMAN MOTOR NEURON DISEASE [J].
LATOV, N ;
HAYS, AP ;
DONOFRIO, PD ;
LIAO, J ;
ITO, H ;
MCGINNIS, S ;
MANOUSSOS, K ;
FREDDO, L ;
SHY, ME ;
SHERMAN, WH ;
CHANG, HW ;
GREENBERG, HS ;
ALBERS, JW ;
ALESSI, AG ;
KEREN, D ;
YU, RK ;
ROWLAND, LP ;
KABAT, EA .
NEUROLOGY, 1988, 38 (05) :763-768
[5]   MEASUREMENT AND SIGNIFICANCE OF ANTIBODIES AGAINST GM1 GANGLIOSIDE - REPORT OF A WORKSHOP, 18 APRIL 1989, CHICAGO, IL, USA [J].
MARCUS, DM ;
LATOV, N ;
HSI, BP ;
GILLARD, BK .
JOURNAL OF NEUROIMMUNOLOGY, 1989, 25 (2-3) :255-259
[6]  
NARDELLI E, 1987, J NEUROIMMUNOL, V16, P132
[7]   MOTOR-NEURON DISEASE IN A PATIENT WITH A MONOCLONAL IGMK DIRECTED AGAINST GM1, GD1B, AND HIGH-MOLECULAR-WEIGHT NEURAL-SPECIFIC GLYCOPROTEINS [J].
NOBILEORAZIO, E ;
LEGNAME, G ;
DAVERIO, R ;
CARPO, M ;
GIULIANI, A ;
SONNINO, S ;
SCARLATO, G .
ANNALS OF NEUROLOGY, 1990, 28 (02) :190-194
[8]   ANTI-GM1 IGM ANTIBODIES IN MOTOR-NEURON DISEASE AND NEUROPATHY [J].
NOBILEORAZIO, E ;
CARPO, M ;
LEGNAME, G ;
MEUCCI, N ;
SONNINO, S ;
SCARLATO, G .
NEUROLOGY, 1990, 40 (11) :1747-1750
[9]   GUILLAIN-BARRE-SYNDROME ASSOCIATED WITH HIGH TITERS OF ANTI-GM1 ANTIBODIES [J].
NOBILEORAZIO, E ;
CARPO, M ;
MEUCCI, N ;
GRASSI, MP ;
CAPITANI, E ;
SCIACCO, M ;
MANGONI, A ;
SCARLATO, G .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1992, 109 (02) :200-206
[10]  
NORES GA, 1991, J BIOCHEM, V110, P1